AKRO - Akero Therapeutics Inc. Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm | Benzinga
Investors can contact the law firm at no cost to learn more about recovering their losses
LOS ANGELES, June 06, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Akero Therapeutics, Inc. ("Akero" or the "Company") (NASDAQ:AKRO) investors that a class action has been filed on behalf of investors. Akero investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq.
Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: lesley@portnoylaw.com, to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recover their losses.
Akero is a clinical-stage drug development company that has yet to generate any revenue as the FDA has not approved any of its drug candidates for ...